Literature DB >> 21670769

Autoimmunity: Does autoantigen complementarity underlie PR3-ANCA AAV?

Gloria Preston, Ronald Falk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670769     DOI: 10.1038/nrrheum.2011.86

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals.

Authors:  S Oak; J Radtke; C Törn; M Landin-Olsson; C S Hampe
Journal:  Scand J Immunol       Date:  2011-10       Impact factor: 3.487

Review 2.  Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA.

Authors:  J E Blalock
Journal:  Trends Biotechnol       Date:  1990-06       Impact factor: 19.536

Review 3.  Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application.

Authors:  Athanasios G Tzioufas; John G Routsias
Journal:  Autoimmun Rev       Date:  2010-05-15       Impact factor: 9.754

4.  DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

Authors:  Yali Cao; John L Schmitz; Jiajin Yang; Susan L Hogan; Donna Bunch; Yichun Hu; Caroline E Jennette; Elisabeth A Berg; Frank C Arnett; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 10.121

5.  [Specific selective interaction between amino acid groups of polypeptide chains].

Authors:  L B Mekler
Journal:  Biofizika       Date:  1969 Jul-Aug

6.  Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants.

Authors:  John G Routsias; Evgenia Touloupi; Eleni Dotsika; Avrilia Moulia; Vassilios Tsikaris; Constantinos Sakarellos; Maria Sakarellos-Daitsiotis; Haralampos M Moutsopoulos; Athanasios G Tzioufas
Journal:  Mol Med       Date:  2002-06       Impact factor: 6.354

7.  Longitudinal studies of patients with ANCA vasculitis demonstrate concurrent reactivity to complementary PR3 protein segments cPR3m and cPR3C and with no reactivity to cPR3N.

Authors:  Peter Hewins; Frances Belmonte; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  Autoimmunity       Date:  2010-08-16       Impact factor: 2.815

8.  Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis.

Authors:  David J Bautz; Gloria A Preston; Sofia Lionaki; Peter Hewins; Alisa S Wolberg; Jia Jin Yang; Susan L Hogan; Hyunsook Chin; Stephan Moll; J Charles Jennette; Ronald J Falk
Journal:  J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 10.121

9.  Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis.

Authors:  Henko Tadema; Cees G M Kallenberg; Coen A Stegeman; Peter Heeringa
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

10.  Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.

Authors:  William F Pendergraft; Gloria A Preston; Ruchir R Shah; Alexander Tropsha; Charles W Carter; J Charles Jennette; Ronald J Falk
Journal:  Nat Med       Date:  2003-12-07       Impact factor: 87.241

  10 in total
  3 in total

Review 1.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

Review 2.  ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.

Authors:  Divi Cornec; Emilie Cornec-Le Gall; Fernando C Fervenza; Ulrich Specks
Journal:  Nat Rev Rheumatol       Date:  2016-07-28       Impact factor: 20.543

Review 3.  Pathophysiological Relationship between Infections and Systemic Vasculitis.

Authors:  Carolina Muñoz-Grajales; Juan C Pineda
Journal:  Autoimmune Dis       Date:  2015-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.